Elanco
Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.
DitchCarbon Score
How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elanco's score of 51 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elanco's reported carbon emissions
In 2023, Elanco reported total carbon emissions of approximately 1,439,342,000 kg CO2e, comprising 145,020,000 kg CO2e from Scope 1, 170,239,000 kg CO2e from Scope 2, and 624,083,000 kg CO2e from Scope 3 emissions. This marked a significant increase from previous years, with total emissions in 2022 at about 1,017,744,000 kg CO2e and in 2021 at approximately 1,108,532,000 kg CO2e. Elanco has committed to achieving net-zero emissions across all scopes by 2050, as part of its long-term climate strategy. The company has also set interim targets through the Science Based Targets initiative (SBTi), demonstrating its commitment to reducing its carbon footprint in alignment with global climate goals. The emissions intensity for Scope 1 and 2 in 2023 was approximately 0.071 kg CO2e per USD of revenue, reflecting ongoing efforts to improve operational efficiency. Elanco's emissions data indicates a proactive approach to sustainability, with a focus on reducing both direct and indirect emissions across its value chain.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elanco is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
